ATF4 and acute myeloid leukemia: Mechanistic studies of the anti-AML activity of atovaquone revealed that it induced the ISR, with increased phosphorylation of eIF2α and ATF4 protein levels while also increasing mRNA levels of numerous pro-apoptotic ATF4 target genes, including CHOP [79].